Literature DB >> 24297266

[Austrian 3e-recommendations for diagnosis and management of gout 2013].

Judith Sautner1, Johann Gruber, Manfred Herold, Jochen Zwerina, Burkhard F Leeb.   

Abstract

BACKGROUND: Gout is the most common inflammatory joint disease in the Western world, with increasing prevalence. Like former 3e-initiatives (Experts-Evidence-Education) dealing with other rheumatological problems, this initiative aimed at the development of international recommendations for the diagnosis and management of gout and hyperuricemia based on a systematic literature research.
METHODS: In the participating countries 10 national questions were generated via a Delphi-process. These questions were collected and out of this pool 10 international questions were formulated. Afterwards a systematic literature research was performed. On that basis again first national and afterwards international recommendations were generated.
RESULTS: On the basis of the available literature an Austrian expert panel developed 10 recommendations on diagnosis and management of gout and hyperuricemia. After publication of the international 3e-recommendations we hereby present the national Austrian questions and expert-recommendations for diagnosis and management of gout 2013 followed by a comparison of the Austrian and the international recommendations.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24297266     DOI: 10.1007/s00508-013-0469-1

Source DB:  PubMed          Journal:  Wien Klin Wochenschr        ISSN: 0043-5325            Impact factor:   1.704


  46 in total

1.  Significance of serum uric acid levels on the risk of all-cause and cardiovascular mortality.

Authors:  Chang-Fu Kuo; Lai-Chu See; Kuang-Hui Yu; I-Jun Chou; Meng-Jiun Chiou; Shue-Fen Luo
Journal:  Rheumatology (Oxford)       Date:  2012-08-25       Impact factor: 7.580

2.  2012 American College of Rheumatology guidelines for management of gout. Part 2: therapy and antiinflammatory prophylaxis of acute gouty arthritis.

Authors:  Dinesh Khanna; Puja P Khanna; John D Fitzgerald; Manjit K Singh; Sangmee Bae; Tuhina Neogi; Michael H Pillinger; Joan Merill; Susan Lee; Shraddha Prakash; Marian Kaldas; Maneesh Gogia; Fernando Perez-Ruiz; Will Taylor; Frédéric Lioté; Hyon Choi; Jasvinder A Singh; Nicola Dalbeth; Sanford Kaplan; Vandana Niyyar; Danielle Jones; Steven A Yarows; Blake Roessler; Gail Kerr; Charles King; Gerald Levy; Daniel E Furst; N Lawrence Edwards; Brian Mandell; H Ralph Schumacher; Mark Robbins; Neil Wenger; Robert Terkeltaub
Journal:  Arthritis Care Res (Hoboken)       Date:  2012-10       Impact factor: 4.794

3.  Colchicine for prophylaxis of acute flares when initiating allopurinol for chronic gouty arthritis.

Authors:  Gregory C Borstad; Leslie R Bryant; Michael P Abel; Daren A Scroggie; Mark D Harris; Jeff A Alloway
Journal:  J Rheumatol       Date:  2004-12       Impact factor: 4.666

4.  Effect of urate-lowering therapy on the velocity of size reduction of tophi in chronic gout.

Authors:  Fernando Perez-Ruiz; Marcelo Calabozo; Jose I Pijoan; Ana M Herrero-Beites; Ana Ruibal
Journal:  Arthritis Rheum       Date:  2002-08

Review 5.  Metabolic syndrome, diabetes, and hyperuricemia.

Authors:  Changgui Li; Ming-Chia Hsieh; Shun-Jen Chang
Journal:  Curr Opin Rheumatol       Date:  2013-03       Impact factor: 5.006

6.  Ultrasonographic measurement of tophi as an outcome measure for chronic gout.

Authors:  Fernando Perez-Ruiz; Iñaki Martin; Begoña Canteli
Journal:  J Rheumatol       Date:  2007-07-15       Impact factor: 4.666

7.  Purine-rich foods, dairy and protein intake, and the risk of gout in men.

Authors:  Hyon K Choi; Karen Atkinson; Elizabeth W Karlson; Walter Willett; Gary Curhan
Journal:  N Engl J Med       Date:  2004-03-11       Impact factor: 91.245

8.  Asymptomatic hyperuricemia. Risks and consequences in the Normative Aging Study.

Authors:  E W Campion; R J Glynn; L O DeLabry
Journal:  Am J Med       Date:  1987-03       Impact factor: 4.965

9.  Soft drinks, fructose consumption, and the risk of gout in men: prospective cohort study.

Authors:  Hyon K Choi; Gary Curhan
Journal:  BMJ       Date:  2008-01-31

10.  Canakinumab reduces the risk of acute gouty arthritis flares during initiation of allopurinol treatment: results of a double-blind, randomised study.

Authors:  Naomi Schlesinger; Eduardo Mysler; Hsiao-Yi Lin; Marc De Meulemeester; Jozef Rovensky; Udayasankar Arulmani; Alison Balfour; Gerhard Krammer; Peter Sallstig; Alexander So
Journal:  Ann Rheum Dis       Date:  2011-05-03       Impact factor: 19.103

View more
  4 in total

1.  [Diagnosis and management of gout in Austria. Survey of current practice considering the EULAR recommendations].

Authors:  J Sautner
Journal:  Z Rheumatol       Date:  2014-11       Impact factor: 1.372

2.  [Austrian nutrition and lifestyle recommendations for gout and hyperuricemia].

Authors:  J Sautner; G Eichbauer-Sturm; J Gruber; R Puchner; P Spellitz; C Strehblow; J Zwerina; G Eberl
Journal:  Z Rheumatol       Date:  2015-09       Impact factor: 1.372

3.  Effect of rosuvastatin on hyperuricemic rats and the protective effect on endothelial dysfunction.

Authors:  Dilidaer Xilifu; Abulizi Abudula; Nijiati Rehemu; Long Zhao; Xinrong Zhou; Xiangyang Zhang
Journal:  Exp Ther Med       Date:  2014-10-15       Impact factor: 2.447

4.  2022 update of the Austrian Society of Rheumatology and Rehabilitation nutrition and lifestyle recommendations for patients with gout and hyperuricemia.

Authors:  Judith Sautner; Gabriela Eichbauer-Sturm; Johann Gruber; Raimund Lunzer; Rudolf Johannes Puchner
Journal:  Wien Klin Wochenschr       Date:  2022-07-11       Impact factor: 2.275

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.